{"schema_version":"secwatch.filing_event.v1","accession":"0000046250-23-000005","form_type":"8-K","ticker":"HWKN","cik":"0000046250","company_name":"HAWKINS INC","filed_at":"2023-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.705866+00:00","generated_at":"2026-06-20T04:16:25.812736+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Hawkins reports record Q3 fiscal 2023: sales $219.2M (+17%), EPS $0.51 (+6%)","bullets":["Net income $10.7M ($0.51 diluted) vs $10.2M ($0.48) in prior year quarter.","Water Treatment sales +38% to $68.5M; Industrial +14% to $114.4M; Health and Nutrition -1%.","LIFO expense of $3.7M ($12.7M YTD) reduced gross profit; gross margin 17% vs 18% a year ago.","Adjusted EBITDA $23.8M (+10%); operating cash flow $25.7M; debt reduced $10M; leverage 1.14x.","Year-to-date EPS $2.31 (+19%); management expects continued Health and Nutrition softness in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0000046250-23-000005","json":"https://secwatch.observer/filing/0000046250-23-000005.json","markdown":"https://secwatch.observer/filing/0000046250-23-000005.md","text":"https://secwatch.observer/filing/0000046250-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/46250/000004625023000005/0000046250-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/46250/000004625023000005/hwkn-20230201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T04:16:25.812736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"709ce8f672a9f521cde26cf21823b02234f230f8","claim":"HAWKINS INC reported fiscal 2023 third quarter ended January 1, 2023 results: revenue $219.2 million, net income $10.7 million, EPS $0.51 per diluted share.","evidence_excerpt":"For the third quarter of fiscal 2023, the Company reported net income of $10.7 million, or $0.51 per diluted share, compared to net income for the third quarter of fiscal 2022 of $10.2 million, or $0.48 per diluted share. REVENUE Sales were $219.2 million for the third quarter of fiscal 2023, an increase of $32.1 million, or 17%, from sales of $187.1 million in the same period a year ago, driven primarily by increased selling prices.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/46250/000004625023000005/0000046250-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2023 third quarter ended January 1, 2023"},{"label":"Revenue","value":"$219.2 million"},{"label":"Net income","value":"$10.7 million"},{"label":"EPS","value":"$0.51 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}